Consonance Capital Management L.P. is an investment fund managing more than $7.07 million ran by Gabriela Franco. There is currently 1 company in Mrs. Franco’s portfolio. The largest and only investment include Surrozen Inc worth $7.07 million.
As of 7th November 2022, Consonance Capital Management L.P.’s top holding is 3,497,500 shares of Surrozen Inc currently worth over $7.07 million and making up 100.0% of the portfolio value.
Currently, Consonance Capital Management L.P.'s portfolio is worth at least $7.07 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Consonance Capital Management L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Gabriela Franco serves as the Chief Compliance Officer at Consonance Capital Management L.P..
There are companies that Consonance Capital Management L.P. is getting rid of from its portfolio.
Consonance Capital Management L.P. closed its position in Silence Therapeutics plc on 14th November 2022.
It sold the previously owned 634,270 shares for $7.52 million.
The two most similar investment funds to Consonance Capital Management L.P. are Kpcb Dgf Ii Associates and Founders Fund Vi Management. They manage $7.06 million and $7.08 million respectively.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Silence Therapeutics plc |
Closed
634,270
|
$7,516,000 | |
| Surrozen Inc |
No change
3,497,500
|
$7,065,000 | 100.00% |
| Compass Therapeutics Inc |
Closed
1,603,789
|
$4,218,000 | |
| United Therapeutics Corp |
Closed
2,998
|
$706,000 | |
| Globus Med Inc |
Closed
5,405
|
$303,000 | |
| Tandem Diabetes Care Inc |
Closed
4,294
|
$254,000 | |
| No transactions found | |||
| Showing first 500 out of 6 holdings | |||